| 1 |
33216460 | Renin profiling predicts neurohormonal response to sacubitril/valsartan. | 2021 Feb |
4 |
| 2 |
34945112 | Effect of the Renin-Angiotensin-Aldosterone System Reactivity on Endothelial Function and Modulative Role of Valsartan in Male Subjects with Essential Hypertension. | 2021 Dec 13 |
1 |
| 3 |
32186406 | Current evidence of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction. | 2020 Jul |
1 |
| 4 |
30449127 | Nebivolol/Valsartan: A Novel Antihypertensive Fixed-Dose Combination Tablet. | 2019 Apr |
1 |
| 5 |
31121027 | Are healthcare systems now ready to adopt sacubitril/valsartan as the preferred approach to inhibiting the renin-angiotensin system in chronic heart failure? The culmination of a 20-year journey. | 2019 Oct 21 |
1 |
| 6 |
30281045 | [ANMCO position paper on sacubitril/valsartan in the management of patients with heart failure]. | 2018 Oct |
1 |
| 7 |
28338173 | Valsartan reduces AT1-AA-induced apoptosis through suppression oxidative stress mediated ER stress in endothelial progenitor cells. | 2017 Mar |
1 |
| 8 |
28509722 | Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data. | 2017 Sep |
3 |
| 9 |
26466333 | Sacubitril/Valsartan: A Novel Cardiovascular Combination Agent. | 2016 Jan-Feb |
1 |
| 10 |
26986445 | Fixed-dose combination therapy of nebivolol and valsartan for the treatment of hypertension. | 2016 |
1 |
| 11 |
26992459 | Neprilysin inhibition with sacubitril/valsartan in the treatment of heart failure: mortality bang for your buck. | 2016 Apr |
1 |
| 12 |
27364182 | Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: a meta-analysis. | 2016 Oct |
1 |
| 13 |
25853236 | A Single-Center, Open-Label, 3-Way Crossover Trial to Determine the Pharmacokinetic and Pharmacodynamic Interaction Between Nebivolol and Valsartan in Healthy Volunteers at Steady State. | 2015 Sep-Oct |
1 |
| 14 |
26362831 | Correlations of plasma renin activity and aldosterone concentration with ambulatory blood pressure responses to nebivolol and valsartan, alone and in combination, in hypertension. | 2015 Nov |
2 |
| 15 |
23509108 | Inhibition of the renin-angiotensin system reduces the rise in serum aldosterone in acute coronary syndrome patients with preserved left ventricular function: observations from the AVANT GARDE-TIMI 43 trial. | 2013 Jun |
2 |
| 16 |
21303424 | Renoprotective efficacy of valsartan in chronic non-diabetic proteinuric nephropathies with renin-angiotensin system gene polymorphisms. | 2011 Jul |
1 |
| 17 |
20499825 | [NAVIGATOR: A trial of prevention of cardiovascular complications and type 2 diabetes with valsartan and/or nateglinide]. | 2010 Apr |
1 |
| 18 |
20694060 | Exforge (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impact. | 2010 Jun 15 |
1 |
| 19 |
21111986 | Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: data from the Valsartan Heart Failure Trial (Val-HeFT). | 2010 Dec |
1 |
| 20 |
22111777 | Valsartan/amlodipine single pill combination for the treatment of hypertension. | 2010 Nov |
1 |
| 21 |
19369955 | Pretreatment levels of plasma renin activity predict ambulatory blood pressure response to valsartan in essential hypertension. | 2009 Oct |
1 |
| 22 |
19509012 | Genetic variant of the Renin-Angiotensin system and diabetes influences blood pressure response to Angiotensin receptor blockers. | 2009 Aug |
2 |
| 23 |
18597007 | Homocysteine, renin and aldosterone in patients with Cushing's syndrome. | 2008 Apr |
1 |
| 24 |
17182977 | Bradykinin B(2) receptor does not contribute to blood pressure lowering during AT(1) receptor blockade. | 2007 Mar |
1 |
| 25 |
17658374 | Dual inhibition of the renin system by aliskiren and valsartan. | 2007 Jul 21 |
1 |
| 26 |
17658393 | Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial. | 2007 Jul 21 |
1 |
| 27 |
17702736 | Hormonal and hemodynamic effects of aliskiren and valsartan and their combination in sodium-replete normotensive individuals. | 2007 Sep |
3 |
| 28 |
17905160 | Dual inhibition of the renin system by aliskiren and valsartan. | 2007 Sep 29 |
1 |
| 29 |
14984917 | The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. | 2004 Feb |
1 |
| 30 |
15023936 | Integrating drug pharmacokinetics for phenotyping individual renin response to angiotensin II blockade in humans. | 2004 Apr |
1 |
| 31 |
15579516 | Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption. | 2004 Dec |
2 |
| 32 |
14608833 | [Efficacy of valsartan in the treatment of persistent microalbuminuria in normotensive patients with type 1 diabetes]. | 2003 Sep-Oct |
1 |
| 33 |
14871033 | Effect of an angiotensin II type 1 receptor blocker, valsartan, on neurohumoral factors in patients with hypertension: comparison with a long-acting calcium channel antagonist, amlodipine. | 2003 Dec |
1 |
| 34 |
12002704 | ACE inhibition is superior to angiotensin receptor blockade for renography in renal artery stenosis. | 2002 Mar |
1 |
| 35 |
10836730 | Additive hypotensive effect of angiotensin-converting enzyme inhibition and angiotensin-receptor antagonism in essential hypertension. | 2000 Jun |
1 |
| 36 |
9767420 | The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production. | 1998 Jul |
1 |